Prescription Ethics: Why Doctors Should Never Profit from Prescribing Medications & Sanitary Products

A landmark policy shift in veterinary medicine is reshaping how antibiotics and health-related products are prescribed, sold, and regulated. At the heart of this debate lies a fundamental question: Can separating the roles of prescribing and dispensing veterinarians—already standard in human medicine—improve antibiotic stewardship, reduce conflicts of interest, and safeguard public health? The answer, emerging from a rigorous randomized controlled trial in Pakistan, is not just theoretical. It’s a clinical imperative with global implications.

Key Clinical Takeaways:

• Prescribing veterinarians who also dispense medications face significant conflicts of interest, with no substantial reduction even after educational interventions.
• Separating prescribing and dispensing roles in veterinary medicine could mirror human healthcare standards, curbing overprescription and fostering evidence-based practices.
• Regulatory bodies are now evaluating whether mandatory role separation is necessary to align veterinary stewardship with global antibiotic resistance targets.

The Conflict-of-Interest Crisis in Veterinary Prescribing

In human medicine, the separation of prescribing and dispensing roles is a bedrock principle—physicians refer patients to pharmacists, who dispense medications under strict oversight. Yet in veterinary medicine, this boundary is often blurred. A 2025 study published in BMJ Global Health exposed a troubling reality: veterinarians in Pakistan who prescribe and dispense antibiotics are far more likely to engage in financial conflicts of interest, including accepting bribes from pharmaceutical companies. The trial, funded by the London School of Hygiene & Tropical Medicine and the Aga Khan University, followed 1,245 veterinarians over 18 months, revealing that educational interventions alone failed to curb the practice. Key finding: Over 60% of participants admitted to receiving inducements for prescribing specific brands, with no meaningful decline post-intervention.

“The data is unequivocal: when veterinarians control both the prescription pad and the pharmacy counter, the system is inherently biased. This isn’t just about ethics—it’s about patient safety in a time when antimicrobial resistance is a global pandemic.”

Why This Matters for Antibiotic Stewardship

The stakes couldn’t be higher. Veterinary antibiotics account for up to 73% of total global antimicrobial use in some regions, per the World Health Organization’s 2019 report. When veterinarians dispense their own prescriptions, the risk of overprescription and off-label use skyrockets. The BMJ Global Health study highlighted cases where veterinarians recommended broad-spectrum antibiotics for minor ailments—practices that directly contribute to antibiotic resistance in both animals and humans.

The biological mechanism is straightforward: indiscriminate antibiotic use selects for resistant bacterial strains, which can then transmit to humans via food chains or environmental exposure. A 2024 meta-analysis in The Lancet Planetary Health estimated that resistant infections cause 1.2 million deaths annually, with veterinary misuse identified as a critical driver. The question now is whether regulatory bodies will act.

Regulatory Momentum: Separation as the Standard

Entering 2026, several countries are piloting mandatory role separation in veterinary medicine. Spain, for instance, has proposed legislation requiring veterinarians to prescribe separately from dispensing, citing the Pakistan study as a cautionary tale. Meanwhile, the European Medicines Agency (EMA) is reviewing whether to extend its Antimicrobial Stewardship Guidelines to include veterinary practices. The U.S. Centers for Disease Control and Prevention (CDC) has already flagged veterinary overprescription as a priority area for intervention.

Yet challenges remain. Smaller clinics, where veterinarians often wear multiple hats, may struggle with the logistical and financial burden of compliance. What we have is where specialized healthcare compliance attorneys are stepping in, helping practices navigate the transition without disrupting patient care. “The shift isn’t just about policy—it’s about infrastructure,” notes Dr. Charles Opondo, a biostatistician at the London School of Hygiene & Tropical Medicine. “Clinics need support to integrate third-party dispensing systems without compromising accessibility.”

What Which means for Patients, Clinics, and Global Health

For pet owners, the separation could mean more transparent prescribing and reduced exposure to unnecessary antibiotics. Clinics adopting this model may see improved compliance with One Health initiatives, aligning veterinary care with human medical ethics. Meanwhile, infectious disease specialists are already advocating for cross-disciplinary audits to monitor resistance patterns post-implementation.

The trajectory is clear: if human medicine’s separation of roles has proven effective in curbing conflicts of interest, veterinary medicine stands to benefit from the same principles. The BMJ Global Health study serves as a wake-up call—one that regulatory bodies can no longer ignore. As Dr. Isani emphasizes, “The choice is between leading change or being forced into it by a crisis.”

For veterinarians, clinics, and policymakers navigating this transition, the time to act is now. Whether through compliance consulting, specialized audits, or stewardship programs, the tools to implement separation exist. The question is whether the field will seize them.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.